𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of the SART1 tumor-rejection antigens in colorectal cancers

✍ Scribed by Teruo Sasatomi; Hideaki Yamana; Shigeki Shichijo; Shoko Tanaka; Torahiko Okamura; Yutaka Ogata; Kyogo Itoh; Kazuo Shirouzu

Publisher
Springer
Year
2000
Tongue
English
Weight
644 KB
Volume
43
Category
Article
ISSN
0012-3706

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of the SART-1 tumor rejection
Expression of the SART-1 tumor rejection antigen in breast cancer
✍ Mayumi Kawamoto; Shigeki Shichijo; Yasuhisa Imai; Toshihiko Imaizumi; Toshihiro πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 127 KB πŸ‘ 2 views

We investigated in breast cancers the expression of the SART-1 gene encoding tumor rejection antigens. SART-1 mRNA was expressed in all of the samples tested. The SART-1 800 antigen was detectable in 20 of 50 (40%) breast cancer tissues and all breast cancer cell lines tested, but not in normal brea

Expression of the tumor-rejection antige
Expression of the tumor-rejection antigen SART1 in brain tumors
✍ Toshihiro Imaizumi; Terukazu Kuramoto; Kazuko Matsunaga; Shigeki Shichijo; Shige πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 156 KB πŸ‘ 2 views

We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm

Expression of tumor rejection antigens i
Expression of tumor rejection antigens in colorectal carcinomas
✍ Teruo Sasatomi; Yuichi Suefuji; Kazuko Matsunaga; Hideaki Yamana; Yoshiaki Miyag πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 143 KB

## Abstract ## BACKGROUND The authors recently reported that the SART2 and SART3 antigens encode tumor epitopes recognized by HLA‐A24‐restricted and tumor‐specific cytotoxic T lymphocytes (CTLs) established from esophageal carcinoma patients. The current study investigated these antigens to explor

Expression of stress protein gp96, a tum
Expression of stress protein gp96, a tumor rejection antigen, in human colorectal cancer
✍ Michael Heike; Christian Frenzel; Dieter Meier; Peter R. Galle πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 345 KB πŸ‘ 2 views

Preparations of stress protein gp96 from tumor cells are active as tumor vaccines by eliciting immune responses against mixtures of individual tumor peptide antigens which are complexed to gp96. Due to the individual antigenicity of tumors, a vaccine consisting of tumor-derived gp96 has to be prepar

Role of tumor-associated antigen express
Role of tumor-associated antigen expression in radioimmunoguided surgery for colorectal and breast cancer
✍ Sergio Bertoglio; Pierluigi Percivale; Federico Schenone; Alberto Peressini; Car πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 68 KB πŸ‘ 2 views

One hundred thirty-six patients with colorectal and breast cancer were enrolled in a retrospective study using radioimmunoguided surgery (RIGS) with Iodine-125 (I 125 ) radiolabeled B72.3 (Group A, 73 patients) and F023C5 (Group B, 63 patients) monoclonal antibodies (MAbs). The correlation between i